Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Nomura expects the Reserve Bank of India to raise interest rates by another 25 basis points in December.

Nomura expects the Reserve Bank of India to raise interest rates by another 25 basis points in December.

智通财经智通财经2026/10/08 02:21
Show original

Nomura analysts stated in a report that the Reserve Bank of India unexpectedly shifted its policy stance from "neutral" to "orderly tightening" in order to stabilize inflation expectations and build a buffer against a globally adverse environment. The investment bank expects the Reserve Bank of India to raise rates by another 25 basis points in December and then pause, which contrasts with the market's expectation of a longer rate hike cycle. The Reserve Bank of India has raised its GDP growth and inflation forecasts for the 2026/27 fiscal year to 7.1% and 5.2%, respectively, and has also raised its inflation forecast for the coming year to 5.6%.

Nomura analysts stated in a report that the Reserve Bank of India unexpectedly shifted its policy stance from "neutral" to "orderly tightening," aiming to stabilize inflation expectations and build a buffer against adverse global conditions. The investment bank anticipates that the Reserve Bank of India will raise rates by another 25 basis points in December before pausing hikes, contrasting with market expectations that the rate hike cycle will last longer. The Reserve Bank of India has raised its GDP growth and inflation forecasts for fiscal 2026/27 to 7.1% and 5.2% respectively, and raised its inflation forecast for the coming year to 5.6%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Pfizer (PFE.US) Tukysa receives U.S. approval for first-line breast cancer treatment

According to Zhitong Finance APP, Pfizer (PFE.US) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its tyrosine kinase inhibitor Tukysa (tucatinib) as part of a combination therapy for first-line maintenance treatment of a certain type of breast cancer.

智通财经•2026/10/08 02:41

Xpeng Robotaxi launches its Chinese name "Xpeng Youyou" and expands the range of internal test users

On October 8, XPeng Group officially launched the Chinese name "小鹏悠游" for its Robotaxi business, with the English name "XPENGYOYO". On the same day, the official XPeng Group website went live with a Robotaxi product page, and the online ordering mini-program "XPENGYOYO Autonomous Driving" was launched simultaneously. The company will further expand the scope of its internal testing users by distributing invitation codes. This marks XPeng Robotaxi’s official transition from technology verification to a new phase of user access and business exploration.

智通财经•2026/10/08 02:31

Shanghai fuel oil futures surpass 5,000 yuan/ton, up 14.40% intraday

Shanghai fuel oil futures have just surpassed the 5,000 yuan/ton mark, currently quoted at 5,006 yuan/ton, up 14.40% for the day.

智通财经•2026/10/08 02:21
Shanghai fuel oil futures surpass 5,000 yuan/ton, up 14.40% intraday

US crude oil: Range-bound fluctuations, buy on dips and sell on rallies.

Analysis: U.S. crude oil inventories unexpectedly decreased by 3.186 million barrels, far exceeding market expectations. Combined with rising Middle East shipping risks, this provides support for WTI. However, the International Energy Agency accelerated the release of strategic reserves, and supply recovery expectations still limit price increases. Technically, prices remain in a low-level consolidation; watch for a breakthrough at the $90 level. Key focus: geopolitical situation, inventory data, U.S. dollar index, global crude oil supply, and OPEC+ policies. Resistance: 90.00, 91.50, 92.00 Support: 89.00, 88.00, 86.00

智通财经•2026/10/08 02:11
US crude oil: Range-bound fluctuations, buy on dips and sell on rallies.